Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. freshman Avg
|
New words:
absorption, accredited, ADAP, Alan, allergic, allopurinol, Alzheimer, ARB, Atlantic, back, Berna, bioavailability, bus, cannabinoid, capsaicin, Cardiome, carnitine, ceiling, CFO, cleared, compromised, contractor, Dear, difficultly, disposition, disseminate, DSM, economy, elucidating, embody, euro, eventual, febuxistat, Fleetwood, Florida, frame, France, front, Fulbright, furniture, Hall, hope, hyalurunate, hypothetical, IMS, inevitably, inflammation, insert, interaction, Internet, intolerant, investee, Ireland, issuer, Jaworski, judge, JV, landlord, leukemic, lost, Marco, margin, methodology, MHRA, mitigate, municipal, municipality, neurophilin, Nova, overstatement, owner, oxypurinol, Pharma, pharmacovigilance, pledged, posted, posting, postpone, prejudice, prerequisite, professional, purpose, ratio, reacquired, receptor, redesign, reintroduction, replied, reproducible, resale, residual, resold, retroactively, rheumatology, Rider, Rubinfeld, saleable, savient, Seton, slower, stem, step, stipulation, stockpile, stockpiled, substantive, succeed, sum, SVNT, Synvisc, Tatum, titration, transportation, Turkey, unamortized, uncollectible, uncontrolled, underperformance, underway, urology, user, verification, verified, viscosupplementation, Vitaquest, Viva, waiver, warfarin, worth, wound
Removed:
admitted, advertising, affiliate, American, AML, amounting, analog, Antibiotici, assessed, asthma, authorized, BASF, Beecham, bGH, blinded, Bordeaux, bound, BPD, bronchopulmonary, cellular, compulsory, confidential, confirm, Consent, controlled, controller, corrected, counterclaimed, CPA, cytotoxic, department, desire, dismutase, Du, duly, dysplasia, enjoined, excrete, exhibit, Fish, focusing, generating, Haft, infeasible, Intercredit, Junior, Laser, Lechner, leukemia, lipodystrophy, listed, lung, mechanical, Missouri, Neave, omitted, oncology, OXSODROL, oxygen, Pennsylvania, placebo, Pont, postnatal, premature, preservation, Prodotti, promotional, protective, proved, reactivation, reactive, recently, redistribution, Reorganization, respiratory, returned, revealed, Robert, SAIZEN, Secretary, Serono, Shaw, SmithKline, Societa, SOD, Solchem, SPA, Sternlicht, stream, suggested, superoxide, Synnestvedt, Textile, thereunto, transmission, Trust, undersigned, undertook, ventilation, viral, Yeda, Yehuda
Filing tables
Filing exhibits
SVNT similar filings
Filing view
External links
Exhibit 23.2
CONSENT OF INDEPENDENT CERTIFIED PUBLIC ACCOUNTANTS
We have issued our report dated February 16, 2004, accompanying the consolidated financial statements of Savient Pharmaceuticals, Inc. as of and for the years ended December 31, 2002 and 2003 included in the Annual Report of Savient Pharmaceuticals, Inc. on Form 10-K for the year ended December 31, 2003. We hereby consent to the incorporation by reference of said report in the registration statements No. 33-51202, 33-83904, 33-69870, 33-41591, 33-41593, 333-36121, 333-33073, 333-33075, 333-64541, and 333-87344 on Form S-8 of Savient Pharmaceuticals, Inc.
/s/ Grant Thornton LLP |
New York, New York |
March 12, 2004 |